2.9(top 20%)
impact factor
633(top 20%)
papers
5.1K(top 20%)
citations
31(top 20%)
h-index
3.2(top 20%)
impact factor
820
all documents
5.9K
doc citations
42(top 20%)
g-index

Top Articles

#TitleJournalYearCitations
1Pharmacists at the frontline beating the COVID-19 pandemicJournal of Pharmaceutical Policy and Practice2020129
2Assessment of WHO/INRUD core drug use indicators in two tertiary care hospitals of Bahawalpur, Punjab, PakistanJournal of Pharmaceutical Policy and Practice201678
3Pharmacists and COVID-19Journal of Pharmaceutical Policy and Practice202078
4Mental health issues impacting pharmacists during COVID-19Journal of Pharmaceutical Policy and Practice202073
5Understanding the factors influencing healthcare providers’ burnout during the outbreak of COVID-19 in Jordanian hospitalsJournal of Pharmaceutical Policy and Practice202062
6Accrediting retail drug shops to strengthen Tanzania’s public health system: an ADDO case studyJournal of Pharmaceutical Policy and Practice201560
7Sale of WHO AWaRe groups antibiotics without a prescription in Pakistan: a simulated client studyJournal of Pharmaceutical Policy and Practice202060
8Assessment of knowledge, attitude and practice towards disposal of unused and expired pharmaceuticals among community in Harar city, Eastern EthiopiaJournal of Pharmaceutical Policy and Practice201859
9Pharmaceutical supply chain risk assessment in Iran using analytic hierarchy process (AHP) and simple additive weighting (SAW) methodsJournal of Pharmaceutical Policy and Practice201556
10Assessment of current prescribing practices using World Health Organization core drug use and complementary indicators in selected rural community pharmacies in Southern IndiaJournal of Pharmaceutical Policy and Practice201751
11Supplementary protection certificates and their impact on access to medicines in Europe: case studies of sofosbuvir, trastuzumab and imatinibJournal of Pharmaceutical Policy and Practice202050
12Management of COVID-19 vaccines cold chain logistics: a scoping reviewJournal of Pharmaceutical Policy and Practice202250
13Patient-centred innovation to ensure access to diabetes care in Cambodia: the case of MoPoTsyoJournal of Pharmaceutical Policy and Practice201649
14Medicines dispensing practice during the era of COVID-19 pandemic: a commentaryJournal of Pharmaceutical Policy and Practice202148
15Prescription drug coverage in Canada: a review of the economic, policy and political considerations for universal pharmacareJournal of Pharmaceutical Policy and Practice201847
16Assessing knowledge, attitude, practice, and preparedness of hospital pharmacists in Lebanon towards COVID-19 pandemic: a cross-sectional studyJournal of Pharmaceutical Policy and Practice202047
17Medicines and universal health coverage: challenges and opportunitiesJournal of Pharmaceutical Policy and Practice201544
18Establishment of the African Medicines Agency: progress, challenges and regulatory readinessJournal of Pharmaceutical Policy and Practice202144
19Assessment of disposal practices of expired and unused medications among community pharmacies in Anambra State southeast Nigeria: a mixed study designJournal of Pharmaceutical Policy and Practice201943
20To sell or not to sell; the differences between regulatory and community demands regarding access to antibiotics in rural GhanaJournal of Pharmaceutical Policy and Practice201841
21An analysis of pharmacy workforce capacity in NigeriaJournal of Pharmaceutical Policy and Practice201841
22Herbal medicines: a cross-sectional study to evaluate the prevalence and predictors of use among Jordanian adultsJournal of Pharmaceutical Policy and Practice202041
23Treatment of Febrile illness with artemisinin combination therapy: prevalence and predictors in five African household surveysJournal of Pharmaceutical Policy and Practice201540
24Comparison of hydroxyethyl starch regulatory summaries from the Food and Drug Administration and the European Medicines AgencyJournal of Pharmaceutical Policy and Practice201740
25The impact of clinical services provided by community pharmacies on the Australian healthcare system: a review of the literatureJournal of Pharmaceutical Policy and Practice201839
26Pharmacist intervention amid the coronavirus disease 2019 (COVID-19) pandemic: from direct patient care to telemedicineJournal of Pharmaceutical Policy and Practice202037
27Price and reimbursement of advanced therapeutic medicinal products in Europe: are assessment and appraisal diverging from expert recommendations?Journal of Pharmaceutical Policy and Practice202135
28Estimating proportion of days covered (PDC) using real-world online medicine suppliers’ datasetsJournal of Pharmaceutical Policy and Practice202135
29Promoting transparency, accountability, and access through a multi-stakeholder initiative: lessons from the medicines transparency allianceJournal of Pharmaceutical Policy and Practice201734
30Self medication practice and associated factors among students of Asmara College of Health Sciences, Eritrea: a cross sectional studyJournal of Pharmaceutical Policy and Practice201934
31Saudi Arabia, pharmacists and COVID-19 pandemicJournal of Pharmaceutical Policy and Practice202034
32CoViD vaccines and thrombotic events: EMA issued warning to patients and healthcare professionalsJournal of Pharmaceutical Policy and Practice202134
33Evaluating patients’ perceptions regarding generic medicines in JordanJournal of Pharmaceutical Policy and Practice201333
34Medicines discarded in household garbage: analysis of a pharmaceutical waste sample in ViennaJournal of Pharmaceutical Policy and Practice201433
35Regulatory withdrawal of medicines marketed with uncertain benefits: the bevacizumab case studyJournal of Pharmaceutical Policy and Practice201533
36Patient access schemes in Asia-pacific markets: current experience and future potentialJournal of Pharmaceutical Policy and Practice201533
37Attitude, barriers and facilitators to practice-based research: cross-sectional survey of hospital pharmacists in Saudi ArabiaJournal of Pharmaceutical Policy and Practice201632
38Exploring the status of retail private drug shops in Bangladesh and action points for developing an accredited drug shop model: a facility based cross-sectional studyJournal of Pharmaceutical Policy and Practice201732
39Analysis of changes in trends in the consumption rates of benzodiazepines and benzodiazepine-related drugsJournal of Pharmaceutical Policy and Practice201832
40The community pharmacy practice change towards patient-centered care in Saudi Arabia: a qualitative perspectiveJournal of Pharmaceutical Policy and Practice202032
41Towards the just and sustainable use of antibioticsJournal of Pharmaceutical Policy and Practice201631
42The Urgent Need for Transparent and Accountable Procurement of Medicine and Medical Supplies in Times of COVID-19 PandemicJournal of Pharmaceutical Policy and Practice202031
43Contribution of antimicrobial stewardship programs to reduction of antimicrobial therapy costs in community hospital with 429 Beds --before-after comparative two-year trial in JapanJournal of Pharmaceutical Policy and Practice201430
44Attitude and satisfaction of health care providers towards clinical pharmacy services in Ethiopia: A post-deployment surveyJournal of Pharmaceutical Policy and Practice201630
45Ten recommendations to improve pharmacy practice in low and middle-income countries (LMICs)Journal of Pharmaceutical Policy and Practice202130
46Assessing public knowledge, attitudes and determinants of third COVID-19 vaccine booster dose acceptance: current scenario and future perspectivesJournal of Pharmaceutical Policy and Practice202230
47Effects of the National Essential Medicine System in reducing drug prices: an empirical study in four Chinese provincesJournal of Pharmaceutical Policy and Practice201429
48Needs assessment and impact of COVID-19 on pharmacy professionals in 31 commonwealth countriesJournal of Pharmaceutical Policy and Practice202029
49Knowledge and attitudes towards antibiotic use and resistance among undergraduate healthcare students at University of RwandaJournal of Pharmaceutical Policy and Practice202028
50Repurposing existing drugs for new uses: a cohort study of the frequency of FDA-granted new indication exclusivities since 1997Journal of Pharmaceutical Policy and Practice202128